Evecxia is developing treatments for severe depression and suicidal ideation which affect 7 million people in the U.S. alone
A first-in-class cell therapy platform that holds the potential to restore vision in the millions of people worldwide with retinal diseases
MAIA reports positive topline safety data from its Phase 2 clinical trial in advanced Non-Small Cell Lung Cancer
GreenWaves Technology has developed a breakthrough new processor specifically designed to power the next generation of AI-powered devices
Belhaven’s needle-free delivery system solves every problem associated with EpiPens, including cost.
A panel discussion on the future of cannabis and innovative financing solutions that are helping drive the industry forward
Inmedix CloudHRV™ Platform provides actionable stress measurements to improve patient outcomes and reduce cost of care.
QSAM has refined an FDA-approved treatment creating a heat seeking missile that has the potential to cure metastatic bone cancer
Gain Therapeutics has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research
bit.bio is unlocking the therapeutic potential of human cells based on a new paradigm – cell reprogramming
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office